For the Inventor, By the Inventor

Enter assignee name

Wilmington, DE, United States of America

Incyte San Diego Inc.

Calculating rank

USPTO Granted Patents = 8

% Expired Patents = 100.0

Forward Citations = 45

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Catherine Tachdjian (8 out of 56 patents)

Hussien A Al-Shamma (7 out of 13 patents)

Magnus Pfahl (7 out of 24 patents)

4. Lyle W Spruce (6 out of 34 patents)

5. Andrea Fanjul (5 out of 8 patents)

6. David P M Pleynet (4 out of 7 patents)

7. Karine Jakubowicz-Jaillardon (3 out of 3 patents)

8. James Zapf (2 out of 6 patents)

9. Jianhua Guo (2 out of 4 patents)

10. Andrea Fanjul Giachino (2 out of 2 patents)

11. Torsten R Wiemann (2 out of 8 patents)

12. Mohamed Boudjelal (2 out of 2 patents)

13. Richard Masten Fine (1 out of 19 patents)

14. David Pm Pleynet (1 out of 1 patent)

15. Jason B Ibarra (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 7265139 - RXR activating molecules (2007-09-04),

2. 7226940 - Substituted heterocycles for the treatment of diabetes and other diseases (2007-06-05),

3. 7196108 - Bicyclic heterocycles for the treatment of diabetes and other diseases (2007-03-27),

4. 7153875 - Heterocyclic derivatives for the treatment of cancer and other proliferative diseases (2006-12-26),

5. 7102000 - Heterocyclic amide derivatives for the treatment of diabetes and other diseases (2006-09-05),

6. 7071218 - N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases (2006-07-04),

7. 6974826 - Imidazolidinedione derivatives for the treatment of diabetes and other diseases (2005-12-13),

8. 6765013 - Thiazolidinedione derivatives for the treatment of diabetes and other diseases (2004-07-20),

Company Overview

Incyte San Diego Inc. is a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies to improve the lives of patients with cancer and other serious diseases. With a unique portfolio of proprietary small molecules, the company is dedicated to advancing precision medicine through research and collaboration.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

8 Patents

#391 in Wilmington, DE

#523 in Delaware

#35,954 in US

Wilmington, DE, United States of America

Incyte San Diego Inc.

Forward Citations = 45

15 inventors:

Catherine Tachdjian (8 out of 56 patents)

Hussien A Al-Shamma (7 out of 13 patents)

Magnus Pfahl (7 out of 24 patents)

4. Lyle W Spruce (6 out of 34 patents)

5. Andrea Fanjul (5 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Incyte San Diego Inc.. Retrieved from https://idiyas.com/company/incyte-san-diego

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…